BioNTech (NASDAQ: BNTX) And Pfizer (NYSE: PFE) Files Petition Against CureVac BV (NASDAQ: CVAC) Over Patent Breach

Manufacturer of the COVID-19 vaccine BioNTech (NASDAQ: BNTX) and partner Pfizer (NYSE: PFE) announced on Tuesday that they had lodged a petition with the US District Court in Massachusetts, requesting for a ruling that their actions did not violate US patents claimed by rival CureVac BV (NASDAQ: CVAC). CureVac accused of trying to take advantage […]

Big Pharma Deals: Pfizer Inc. (NYSE: PFE) Partners with Valneva SE in the Fight against Lyme Disease

One of the big pharma entities in the U.S., Pfizer Inc. (NYSE: PFE), just got into a deal with French jab manufacturer Valneva SE. The timing of this deal couldn’t have come at a better time, given the setback and reputational risks that Valneva has been facing in its Covid-19 vaccine candidate disagreement with the […]

Pfizer Inc. (NYSE: PFE) Has Developed a COVID-19 Vaccine For Children Under 5

Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that three shots of its vaccines could offer ample protection for those under five. Pfizer intends to submit its results to regulators. Modern Inc (NASDAQ: MRNA) has developed a vaccine for children under five […]

Pfizer Inc. (NYSE: PFE) Is About to Trade Ex-dividend

Pfizer Inc. (NYSE: PFE) has announced that it will soon trade ex-dividend. This announcement signals the company’s investors to make their moves. The ex-dividend date refers to the day before a company decides which of its shareholders will get a dividend. Pfizer’s dividend will be $0.40 per share. Pfizer announces the real-world benefits of IBRANCE […]

Pfizer Inc. (NYSE: PFE) Finds That Paxlovid Cannot Prevent COVID-19 Infection

Pfizer Inc. (NYSE: PFE) has found that its Paxlovid pill might not effectively prevent COVID-19 in people who have come in contact with infected individuals. Paxlovid is an oral drug which the Food and Drug Administration (FDA) approved for the treatment of COVID-19. In the study, the company gave the pill to people for five […]

Pfizer Inc. (NYSE: PFE) Has Produced 6 Million Paxlovid Pills

Pfizer Inc. (NYSE: PFE) announced that it surpassed the target that Albert Bourla, its CEO, set and developed 6 million Paxlovid pills. Paxlovid is an oral pill that treats COVID-19. The company also stated that it had sent these pills to 26 counties. It hopes to create about 120 million pills in 2022. Meanwhile, the […]

Pfizer Inc. (NYSE: PFE) Gets Breakthrough Therapy Designation For RSVpreF

The U.S Food and Drug Administration (FDA) has given Pfizer Inc. (NYSE: PFE) the Breakthrough Designation for RSVpreF, its vaccine for respiratory syncytial virus (RSV). The vaccine is for people aged 60 and above. This move comes after Pfizer conducted a Phase IIa clinical trial that looked into the efficacy, immunogenicity, and safety of the […]

Pfizer Inc. (NYSE: PFE) Study Shows The Company Gives Equitable Pay to Workers

Pfizer Inc. (NYSE: PFE) has stated for the third time that a compensation expert has recognized that the company offers equitable pay to workers. This announcement came after a study on gender-based pay worldwide and for U.S minorities. It used bonuses, merit increases, and base pay to assess payment equity. The study also adjusted for […]

Pfizer Inc. (NYSE: PFE) Drug, Paxlovid, Becomes Readily Available As Omicron Subsides

The Pfizer Inc. (NYSE: PFE) drug, Paxlovid, is becoming more available as the number of omicron infections dwindles. The drug which the Food and Drug Administration (FDA) approved had been difficult to obtain during the spike, leaving a gap for patients with mild cases of the disease. Meanwhile, Pfizer and BioNTech SE’s (NASDAQ: BNTX) omicron […]

Pfizer Inc. (NYSE: PFE) and Other Biotechnology Service Companies Could Reach a Market Capitalization of $151.10 Billion

Pfizer Inc. (NYSE: PFE) is among the companies in the biotechnology services market that analysts expect to grow in 2022. These companies could amass a market cap of $151.10 billion in 2022. Other significant players in this category include Precision for Medicine, BioAlps, Novo Nordisk, Pfizer, Fisher BioService, and Novartis. The FDA and CDC are […]

Pfizer Inc. (NYSE: PFE) Releases More Data on Its Oral Drug for COVID-19

Pfizer Inc. (NYSE: PFE) has released additional data from the clinical trial of its oral COVID-19 drug. The company found that Paxlovid, the antiviral, was 89% efficient in protecting high-risk populations from dying or hospitalization due to COVID-19. The total dose consists of three pills taken two times a day for five days. It prevents […]

New Approaches to Covid-19 Treatment Enter the Picture

The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (NYSE:PFE), BioNTech SE – ADR (NASDAQ:BNTX), Moderna Inc (NASDAQ:MRNA), AstraZeneca plc (NASDAQ:AZN), Novavax Inc (NASDAQ:NVAX), Halberd Corp (OTCMKTS:HALB), and Johnson & Johnson (NYSE:JNJ). The pandemic is under control. Or is it? In much of the developing world, this is far […]

Novartis (NYSE:NVS) Enters Agreement For Manufacture Of Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) mRNA Vaccine

Novartis (NYSE:NVS) has entered an initial agreement with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for manufacturing support to boost production of their mRNA COVID-19 vaccine to help address supply shortages. This is an example of an unlikely collaboration between big pharmaceutical companies geared at the fight against the coronavirus pandemic. Novartis signs vaccine manufacturing […]

Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) COVID-19 Vaccine Is Safe, Says WHO

The World Health Organisation has said that the Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) vaccine is safe for the elderly despite reports of deaths in Norway. WHO said that the deaths are not attributed to the vaccine and urged vaccination with the vaccine to continue. WHO says Pfizer vaccine is safe On Friday, WHO […]

Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) Delivers 10,000 COVID-19 Doses in Chile As Vaccination Commences

Chile has received 10,000 initial doses of the Pfizer Inc. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) COVID-19 vaccine and commenced vaccinations. The county becomes the first in South America to commence vaccinations against the coronavirus that has so far infected over 584,545 Chileans to date. Chileans skeptical about COVID-19 vaccine The first Chilean to receive the vaccine […]